Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

NCT01265888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension
Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Inhaled Nitric Oxide
DRUG: Inhaled Nitric Oxide
DRUG: Inhaled Nitric Oxide

Sponsor

Geno LLC